How is remifentanil reconstituted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Remifentanil Reconstitution

Remifentanil must be reconstituted by adding 1 mL of diluent per mg of remifentanil powder, shaken well to dissolve, yielding a concentration of approximately 1 mg/mL, and then further diluted to a final concentration of 20,25,50, or 250 mcg/mL before administration—it should never be administered without dilution. 1

Step-by-Step Reconstitution Protocol

Initial Reconstitution

  • Add 1 mL of diluent per mg of remifentanil lyophilized powder 1, 2
  • Shake the vial well to completely dissolve the powder 1
  • This yields a reconstituted solution containing approximately 1 mg/mL of remifentanil 1

Diluent Selection

  • Sterile water or 0.9% saline are the recommended diluents for reconstitution 1, 3
  • Ultrapure water maintains remifentanil stability at pH < 4 for up to 24 hours 3
  • 0.9% saline also maintains stability without significant degradation over 24 hours 3
  • Avoid sodium bicarbonate solutions (pH 8.65), which cause significant remifentanil degradation (P < 0.001) 3

Final Dilution Requirements

After initial reconstitution, remifentanil must be further diluted to one of the following final concentrations before administration 1:

  • 20 mcg/mL: Add reconstituted remifentanil to achieve 1 mg in 50 mL, 2 mg in 100 mL, or 5 mg in 250 mL 1
  • 25 mcg/mL: Add reconstituted remifentanil to achieve 1 mg in 40 mL, 2 mg in 80 mL, or 5 mg in 200 mL 1
  • 50 mcg/mL: Add reconstituted remifentanil to achieve 1 mg in 20 mL, 2 mg in 40 mL, or 5 mg in 100 mL 1
  • 250 mcg/mL: Add reconstituted remifentanil to achieve 5 mg in 20 mL 1

Concentration Selection by Clinical Context

  • Pediatric patients (≥1 year): Use 20 or 25 mcg/mL final concentration 1
  • Monitored anesthesia care: Use 25 mcg/mL final concentration 1
  • General anesthesia maintenance: Any of the four concentrations may be used based on infusion pump capabilities and patient weight 1

Critical Safety Considerations

Administration Requirements

  • Remifentanil must be administered via continuous IV infusion using an infusion device 1
  • The drug should never be administered without dilution from the initial 1 mg/mL reconstituted solution 1

Mixing with Other Agents

  • Do NOT mix remifentanil with propofol in the same syringe 4
  • When remifentanil solution and propofol emulsion are combined, they separate and layer, with remifentanil rising to the top and propofol settling to the bottom 4
  • This separation results in unpredictable and unreliable drug concentrations delivered to patients 4
  • Mixing remifentanil with propofol also substantially increases pH (to approximately 6.50), causing significant remifentanil degradation 3

pH and Stability Concerns

  • Isolated remifentanil remains stable at pH < 4 for 24 hours 3
  • Remifentanil degrades significantly when pH increases above 6.5, which occurs when mixed with propofol or alkaline solutions 3
  • The amount of degradation product detected is proportional to the degree of remifentanil degradation observed 3

Tubing Management

  • Upon discontinuation, the IV tubing must be cleared to prevent inadvertent administration of remifentanil at a later time 1
  • This is critical given remifentanil's potent opioid effects and the risk of respiratory depression 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.